Search Within

Antonio Marcilio Padula Omuro

Formats
  1. Meeting Abstract (105)
  2. Journal Article (96)
  3. Book Section (2)
  4. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (92)
  2. GSK Faculty (57)
  3. Radiology, Department of (46)
  4. Human Oncology and Pathogenesis Program (43)
  5. Neuroradiology Service (41)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Lisa De Angelis (81)
  2. Lauren Abrey (41)
  3. Thomas Kaley (38)
  4. Ingo Mellinghoff (36)
  5. Elena Pentsova (33)
  6. Craig Nolan (26)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (5)

More Years

Publications
  1. Neuro-Oncology (63)
  2. Journal of Clinical Oncology (48)
  3. Journal of Neuro-Oncology (11)
  4. Neurology (8)
  5. Blood (6)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. Oxford University Press (68)
  2. American Society of Clinical Oncology (49)
  3. Springer (17)
  4. Lippincott Williams & Wilkins (11)
  5. Elsevier Inc. (10)
  6. Wiley Blackwell (7)

More Publishers

Results (204)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacotherapy for primary CNS lymphoma: Progress beyond methotrexate?
    Journal Article

    Graber, J. J.; Omuro, A.
    CNS Drugs (2011)

    Fulltext@MSK | Save
  • Bevacizumab and irinotecan (BI) for gliomatous leptomeningeal disease
    Meeting Abstract

    Taillibert, S.; Guillevin, R.; Dehais, C.; Bellanger, A.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with newly diagnosed malignant glioma
    Meeting Abstract

    Nghiemphu, P. L.; Omuro, A. M.; Cloughesy, T.; Mellinghoff, I. K.; Norden, A. G.; Nguyen, L. T.; Rajangam, K.; Wen, P. Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine (PCB), vincristine (VINC), and cytarabine (Ara-C) for primary CNS lymphoma (PCNSL) in elderly patients
    Meeting Abstract

    Omuro, A. M.; Taillandier, L.; Chinot, O. L.; Ghesquieres, H.; Soussain, C.; Delwail, V.; Choquet, S.; Tanguy, M.; Lamy, T.; Hoang-Xuan, K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Immunomagnetic platform technology (IMPT) for the diagnosis of leptomeningeal metastasis in solid tumors (LMST)
    Meeting Abstract

    Nayak, L.; Fleisher, M.; Gonzalez-Espinoza, R.; Reiner, A. S.; Panageas, K.; Lin, O.; Liu, C.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Methotrexate (M) area under the curve (AUC) and creatinine clearance (CrCl) as prognostic factors in primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Panageas, K.; Seko, B.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II trial of TLN-4601 in patients with glioblastoma multiforme (GBM) at first progression
    Meeting Abstract

    Mason, W. P.; Belanger, K.; Nicholas, G. A.; Vallieres, I.; Mathieu, D.; Desjardins, A.; Kavan, P.; Omuro, A. M.; Reymond, D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Antiangiogenic strategies for the treatment of gliomas
    Book Section

    Bazzoli, E.; Omuro, A. M. P.
    In Ray, S. K. (Eds.) Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies (2010)

    Fulltext@MSK | Save